Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Inv. presentation
Appointed director
MARIZYME, INC. (MRZM) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
10/06/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "[email protected]"
10/04/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "PLACEMENT AGENT WARRANT",
"PLACEMENT AGENT WARRANT",
"Marizyme, Inc. 555 Heritage Drive, Suite 205 Jupiter, Florida 33458 October 3, 2023"
08/18/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/31/2023 8-K Quarterly results
07/31/2023 8-K/A Quarterly results
07/18/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
07/12/2023 SC 13G Lichti Braeden reports a 17.9% stake in MARIZYME, INC.
07/12/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "ANNEX A NOTICE OF CONVERSION The undersigned hereby elects to convert principal under the 15% Original Issue Discount Unsecured Subordinated Convertible Promissory Notes, due __, 2024 , in the original principal amount of $_______ , issued by Marizyme, Inc., a Nevada corporation , into shares of common stock, par value $0.001 per share, of the Company according to the conditions hereof, as of the date written below. If shares of Common Stock are to be issued in the name of a person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto and is delivering herewith such certificates and opinions as reasonably requested by the Company in accordance therewith. No fee will be charged to the holder for any conversion, except for such transfer taxes, i...",
"MARIZYME, INC. Class e COMMON STOCK PURCHASE WARRANT Marizyme, Inc., a Nevada corporation , hereby certifies that, for value received, Hexin Global Ltd., an entity , is entitled, subject to the terms set forth below, to purchase from the Company at any time during the Exercise Period up to Fourteen Million Seven Hundred Five Thousand Eight Hundred Eighty-Seven fully paid and non-assessable shares of Common Stock , at a purchase price per share equal to the Exercise Price . The number of shares of Common Stock for which this Class E Common Stock Purchase Warrant is exercisable and the Exercise Price are subject to adjustment as provided herein. 1. DEFINITIONS . Certain terms are used in this Warrant as specifically defined in Section 9 . 2. EXERCISE OF WARRANT . 2.1. Exercise . This Warrant...",
"MARIZYME, INC. Class f COMMON STOCK PURCHASE WARRANT Marizyme, Inc., a Nevada corporation , hereby certifies that, for value received, Hexin Global Ltd., an entity , is entitled, subject to the terms set forth below, to purchase from the Company at any time during the Exercise Period up to Fourteen Million Seven Hundred Five Thousand Eight Hundred Eighty-Seven fully paid and non-assessable shares of Common Stock , at a purchase price per share equal to the Exercise Price . The number of shares of Common Stock for which this Class F Common Stock Purchase Warrant is exercisable and the Exercise Price are subject to adjustment as provided herein. 1. DEFINITIONS . Certain terms are used in this Warrant as specifically defined in Section 9 . 2. EXERCISE OF WARRANT . 2.1. Exercise . This Warrant...",
"11.3",
"Plan of Distribution",
"AMENDMENT TO REGISTRATION RIGHTS AGREEMENT"
05/24/2023 8-K Unregistered Sales of Equity Securities, Financial Statements and Exhibits  Interactive Data
Docs: "MARIZYME, INC. Class E COMMON STOCK PURCHASE WARRANT Marizyme, Inc., a Nevada corporation , hereby certifies that, for value received, Hexin Global Ltd., an entity , is entitled, subject to the terms set forth below, to purchase from the Company at any time during the Exercise Period up to Seven Million Five Hundred Thousand fully paid and non-assessable shares of Common Stock , at a purchase price per share equal to the Exercise Price . The number of shares of Common Stock for which this Class E Common Stock Purchase Warrant is exercisable and the Exercise Price are subject to adjustment as provided herein. 1. DEFINITIONS . Certain terms are used in this Warrant as specifically defined in Section 9 . 2. EXERCISE OF WARRANT . 2.1. Exercise . This Warrant may be exercised prior to its expir...",
"MARIZYME, INC. Class F COMMON STOCK PURCHASE WARRANT Marizyme, Inc., a Nevada corporation , hereby certifies that, for value received, Hexin Global Ltd., an entity , is entitled, subject to the terms set forth below, to purchase from the Company at any time during the Exercise Period up to Three Million Seven Hundred Fifty Thousand fully paid and non-assessable shares of Common Stock , at a purchase price per share equal to the Exercise Price . The number of shares of Common Stock for which this Class F Common Stock Purchase Warrant is exercisable and the Exercise Price are subject to adjustment as provided herein. 1. DEFINITIONS . Certain terms are used in this Warrant as specifically defined in Section 9 . 2. EXERCISE OF WARRANT . 2.1. Exercise . This Warrant may be exercised prior to it..."
05/19/2023 D Form D - Notice of Exempt Offering of Securities:
05/18/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "ANNEX A NOTICE OF CONVERSION The undersigned hereby elects to convert principal under the 15% Original Issue Discount Unsecured Subordinated Convertible Promissory Notes, due __, 2024 , in the original principal amount of $_______ , issued by Marizyme, Inc., a Nevada corporation , into shares of common stock, par value $0.001 per share, of the Company according to the conditions hereof, as of the date written below. If shares of Common Stock are to be issued in the name of a person other than the undersigned, the undersigned will pay all transfer taxes payable with respect thereto and is delivering herewith such certificates and opinions as reasonably requested by the Company in accordance therewith. No fee will be charged to the holder for any conversion, except for such transfer taxes, i...",
"MARIZYME, INC. Class E COMMON STOCK PURCHASE WARRANT Marizyme, Inc., a Nevada corporation , hereby certifies that, for value received, Walleye Opportunities Master Fund Ltd, an entity , is entitled, subject to the terms set forth below, to purchase from the Company at any time during the Exercise Period up to Nine Hundred Eighty Thousand Three Hundred Ninety-Two fully paid and non-assessable shares of Common Stock , at a purchase price per share equal to the Exercise Price . The number of shares of Common Stock for which this Class E Common Stock Purchase Warrant is exercisable and the Exercise Price are subject to adjustment as provided herein. 1. DEFINITIONS . Certain terms are used in this Warrant as specifically defined in Section 9 . 2. EXERCISE OF WARRANT . 2.1. Exercise . This Warra...",
"MARIZYME, INC. Class F COMMON STOCK PURCHASE WARRANT Marizyme, Inc., a Nevada corporation , hereby certifies that, for value received, Walleye Opportunities Master Fund Ltd, an entity , is entitled, subject to the terms set forth below, to purchase from the Company at any time during the Exercise Period up to Nine Hundred Eighty Thousand Three Hundred Ninety-Two fully paid and non-assessable shares of Common Stock , at a purchase price per share equal to the Exercise Price . The number of shares of Common Stock for which this Class F Common Stock Purchase Warrant is exercisable and the Exercise Price are subject to adjustment as provided herein. 1. DEFINITIONS . Certain terms are used in this Warrant as specifically defined in Section 9 . 2. EXERCISE OF WARRANT . 2.1. Exercise . This Warra...",
"PLACEMENT AGENT WARRANT",
"PLACEMENT AGENT WARRANT",
"PLACEMENT AGENT WARRANT",
"11.3",
"Plan of Distribution"
05/10/2023 D Form D - Notice of Exempt Offering of Securities:
05/10/2023 8-K Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran...
Docs: "Marizyme Announces IP Developments for DuraGraft® and its Pipeline Products",
"Marizyme Announces IP Developments for DuraGraft® and its Pipeline of Products"
04/26/2023 8-K/A Quarterly results
04/21/2023 RW Form RW - Registration Withdrawal Request:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2023 8-K Quarterly results
04/13/2023 AW Form AW - Amendment Withdrawal Request:
03/24/2023 10-K Annual Report for the period ended December 31, 2022
02/13/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
02/09/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
02/07/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "MARIZYME, INC. UNSECURED SUBORDINATED PROMISSORY NOTE US $1,000,000 February 6, 2023 FOR VALUE RECEIVED, Marizyme, Inc., a Nevada corporation , promises to pay to Walleye Opportunities Master Fund Ltd , the principal sum of One Million Dollars in lawful money of the United States of America, without interest payable thereon. The principal amount hereof shall be paid in full to the Holder on the ninetieth day following the issuance of this Note . Capitalized terms used herein but not defined herein shall have the meaning ascribed to them in that certain Securities Purchase Agreement, dated of even date herewith , pursuant to which the Holder is acquiring this Unsecured Subordinated Promissory Note . The following is a statement of the rights of the Holder of this Note and the terms and con...",
"MARIZYME, INC. CLASS D COMMON STOCK PURCHASE WARRANT Warrant No.: 01 Initial Exercise Date: ________, 2023 Warrant Value: $2,500,000 THIS CLASS D COMMON STOCK PURCHASE WARRANT certifies that, for value received, Walleye Opportunities Master Fund Ltd or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Public Offering Date ) and on or prior to 5:00 p.m. on___________, 2028 but not thereafter, to subscribe for and purchase from Marizyme, Inc., a Nevada corporation , a number of shares of Common Stock that is equal to the quotient of the Warrant Value as set forth above divided by the Public Offering Price . The purchase price of one Warrant Share under this Warrant shall be equal to the Exe...",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of February 6, 2023, between Marizyme, Inc., a Nevada corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4 of the Securities Act , and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser..."
02/01/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
01/17/2023 8-K Quarterly results
01/05/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
12/28/2022 8-K Quarterly results
12/12/2022 3 Patel Nilesh Umedbhai (Director) has filed a Form 3 on MARIZYME INC
11/16/2022 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/10/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
11/02/2022 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
10/28/2022 PRE 14A Form PRE 14A - Other preliminary proxy statements:
08/18/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy